Abdominal Aortic Aneurysm Clinical Trial
Official title:
Can Emergency Endovascular Aneurysm Repair (eEVAR) Improve the Survival From Ruptured Abdominal Aortic Aneurysm?
The purpose of this trial is to assess whether a strategy of endovascular repair (if aortic morphology is suitable, open repair if not) versus open repair reduces early mortality for patients with suspected ruptured abdominal aortic aneurysm (AAA).
Rupture of the main blood vessel of the body in the abdomen (ruptured abdominal aortic
aneurysm) is fatal in over three-quarters of cases. In the past, those that survive have
reached hospital alive and undergone emergency open surgery to repair the aneurysm and stop
the bleeding: however, after this major emergency surgery only half the patients leave
hospital alive. A newer, less-invasive method of aneurysm repair, endovascular repair, is
based on repairing the aneurysm by inserting the repair graft up through one of the arteries
in the groin. Endovascular repair has been tested in the elective situation and is associated
with a 3-fold reduction in operative mortality versus the standard open surgery. Early work
with selected patients has suggested that endovascular repair may be associated with up to a
2-fold reduction in operative mortality and more rapid recovery for ruptured abdominal aortic
aneurysms. However, only 55-70% patients are anatomically suitable for endovascular repair.
Therefore, this research aims to determine whether a strategy of preferential emergency
endovascular repair reduces both the mortality and cost of ruptured abdominal aortic
aneurysm.
Critically ill patients with a clinical diagnosis of ruptured aneurysm will be randomised, in
the emergency room, to a strategy of endovascular repair if possible (endovascular first) or
to current standard care (immediate transfer to the operating theatre for emergency open
surgery). Patients randomised to "endovascular first" will require a specialist radiological
examination (computed tomography, CT scan) to assess anatomical suitability and plan for
endovascular repair. This will cause a short delay before definitive repair can be commenced.
Those patients not suitable for endovascular repair, after CT scan, will be taken for
standard open surgery. Patients will be randomised at 16-20 specialist centres in the United
Kingdom (UK), who have already attained sufficient experience in using endovascular repair
for ruptured aneurysms and can offer a routine service.
The primary outcome measure is 30-day operative mortality, which we hope will improve by 14%
with the "endovascular first" strategy (from 47% to 33%). Secondary outcome measures include
24h, in-hospital and 1-year and 3-year mortality, re-interventions associated with the two
treatment strategies as well as quality of life, costs and cost-effectiveness.
The research team includes specialists in clinical trials, health economics, statistics,
pre-hospital & emergency care, interventional radiology, vascular & endovascular surgery,
critical care, aneurysm research and a service user.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04227054 -
Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks
|
N/A | |
Active, not recruiting |
NCT03687489 -
Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System
|
N/A | |
Active, not recruiting |
NCT03507413 -
Metformin Therapy in Non-diabetic AAA Patients
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05756283 -
The PREHAAAB Trial: Multimodal Prehabilitation for Patients Awaiting Open Abdominal Aortic Aneurysm Repair
|
N/A | |
Not yet recruiting |
NCT04089241 -
Fusion of CT Angiography With 3D Contrast Ultrasound as a Method for Follow up for Endovascular Aneurysm Repair
|
N/A | |
Active, not recruiting |
NCT02604303 -
A Prospective Analysis on the Expansion Rates of Abdominal Aortic Aneurysms
|
||
Terminated |
NCT02469376 -
Evaluation of a New Imagingtechnologie for Thrombosis
|
Phase 1 | |
Terminated |
NCT01843335 -
Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair
|
N/A | |
Completed |
NCT02229006 -
Sodium Fluoride Imaging of Abdominal Aortic Aneurysms
|
N/A | |
Completed |
NCT02224794 -
LIFE Study: Least Invasive Fast-Track EVAR
|
||
Completed |
NCT01118520 -
AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)
|
Phase 2 | |
Terminated |
NCT01425242 -
Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild Hypertension
|
N/A | |
Completed |
NCT03952780 -
Korean Registry of Percutaneous EVAR With INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
|
||
Completed |
NCT00583414 -
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
|
N/A | |
Recruiting |
NCT05864560 -
Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up
|
||
Completed |
NCT01683084 -
Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms
|
Phase 4 | |
Active, not recruiting |
NCT03180996 -
Global Fenestrated Anaconda Clinical sTudy
|
||
Completed |
NCT02493296 -
The Effect of Surgery on Central Aortic Pressure & haEmodynamics Study
|
||
Completed |
NCT03320408 -
Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers
|
||
Completed |
NCT03837704 -
Comparison of Abdominal Aortic Aneurysm Growth in Adult Smoking Patients Who Either Switch to IQOS, Continue Smoking, or Quit Smoking.
|
N/A |